uic-94003 has been researched along with pl 100 in 1 studies
| Studies (uic-94003) | Trials (uic-94003) | Recent Studies (post-2010) (uic-94003) | Studies (pl 100) | Trials (pl 100) | Recent Studies (post-2010) (pl 100) |
|---|---|---|---|---|---|
| 18 | 0 | 4 | 7 | 0 | 1 |
| Protein | Taxonomy | uic-94003 (IC50) | pl 100 (IC50) |
|---|---|---|---|
| Protease | Human immunodeficiency virus 1 | 0.0005 | |
| Protease | Human immunodeficiency virus 1 | 0.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, ZL; Ghosh, AK; Mitsuya, H | 1 |
1 review(s) available for uic-94003 and pl 100
| Article | Year |
|---|---|
Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV.
Topics: Clinical Trials as Topic; Crystallography, X-Ray; Darunavir; Drug Design; Drug Resistance, Viral; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Ligands; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2007 |